MedTrace Logo

White Fish for Cardiovascular Risk Factors in Patients With Metabolic Syndrome: the WISH-CARE Study

NCT01758601 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 273

Last updated 2017-03-08

No results posted yet for this study

Summary

The investigators performed this study to evaluate the efficacy of regular ingestion of white fish to reduce cardiovascular risk factors in patients with the metabolic syndrome, compared to a diet with no fish or seafood at all.

Conditions

  • Cardiovascular Risk Factors
  • Metabolic Syndrome

Interventions

OTHER

Dietary intervention with 7 servings oh white fish per week (each serve consisted of 100g of frozen Namibia hake, Pescanova S.A., Pontevedra, Spain)

OTHER

Previous alimentary habits, avoiding any significant nutritional imbalance, as well as any fish or seafood

Sponsors & Collaborators

  • CIBER de Fisiopatología de la Obesidad y Nutrición (CIBERobn).

    collaborator UNKNOWN

  • Pescanova S.A., Pontevedra, Spain.

    collaborator UNKNOWN

  • Hospital Universitario Ramon y Cajal

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2011-12-31
Completion
2012-11-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01758601 on ClinicalTrials.gov